Literature DB >> 6660352

Thyroid papillary carcinoma. Pathological and philosophical controversies.

A L Vickery.   

Abstract

An encapsulated thyroid tumor with a papillary architecture is statistically much more likely to be a hyperplastic follicular adenoma than a papillary carcinoma, for the latter are uncommonly encapsulated. Hyperfunction of such a tumor is diagnostic of an adenoma. Various histopathologic features are useful in the differential diagnosis, but these are more accurately termed guidelines than criteria. The presence of psammoma bodies, fibrovascular stalks of papillae and pale nuclear changes are probably the most reliable histopathologic features of a carcinoma. The value of needle biopsy as a diagnostic tool for the screening of thyroid nodules is emphasized. Encapsulated variants of papillary carcinoma are discussed, including the rare pure follicular variant and those intermixed with adenomatous components, suggesting the possibility that some papillary carcinomas might arise in a preexisting adenoma. When the histopathologic diagnosis is equivocal, a benign interpretation is favored since encapsulated papillary carcinomas are very low grade, have an unusually favorable prognosis, and need no further resection. The polarization in past years of clinicians into radical and conservative operative fractions is reviewed. This stemmed from different interpretations of the presence of lymph node metastases in a majority of cases and the high frequency of intraglandular microscopic dissemination of neoplasm. It is clear that biological behavior of this unusual cancer is more important than a literal interpretation of the pathologic findings as a determinant for patient management. The surgical pathologist should be mindful that he plays an important role in patient management, not only by providing a diagnosis but also by serving as a consultant to the surgeon in pathologic correlation.

Entities:  

Mesh:

Year:  1983        PMID: 6660352

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

Review 1.  Our approach to follicular-patterned lesions of the thyroid.

Authors:  Zubair W Baloch; Virginia A LiVolsi
Journal:  J Clin Pathol       Date:  2006-06-23       Impact factor: 3.411

Review 2.  The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid.

Authors:  Sylvia L Asa
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 3.  Problems in the management of solitary nodules and diffuse goitres.

Authors:  A J Webb
Journal:  J R Soc Med       Date:  1998       Impact factor: 5.344

4.  Features associated with locoregional spread of papillary carcinoma correlate with diagnostic category in the Bethesda System for reporting thyroid cytopathology.

Authors:  Paul A VanderLaan; Ellen Marqusee; Jeffrey F Krane
Journal:  Cancer Cytopathol       Date:  2012-03-20       Impact factor: 5.284

Review 5.  The many faces and mimics of papillary thyroid carcinoma.

Authors:  Jorge Albores-Saavedra; Jianhua Wu
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

Review 6.  How to handle borderline/precursor thyroid tumors in management of patients with thyroid nodules.

Authors:  Kennichi Kakudo
Journal:  Gland Surg       Date:  2018-08

7.  Stereology and flow-cytometry of well-differentiated follicular neoplasms of the thyroid gland.

Authors:  T Mattfeldt; G Schürmann; G Feichter
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

8.  The encapsulated follicular variant of papillary thyroid carcinoma: back to the drawing board.

Authors:  Juan Rosai
Journal:  Endocr Pathol       Date:  2010-03       Impact factor: 3.943

9.  [Prognostic criteria of papillary thyroid cancer. Morphologic clinical analysis of 202 cases of tumor].

Authors:  S Schröder; H Dralle; W Rehpenning; W Böcker
Journal:  Langenbecks Arch Chir       Date:  1987

Review 10.  Do benign thyroid nodules have malignant potential? An evidence-based review.

Authors:  Nimmi Arora; Theresa Scognamiglio; Baixin Zhu; Thomas J Fahey
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.